Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ton de Vries

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
JACC. Cardiovascular Interventions|June 25, 2011
A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trialsScot Garg, Giovanna Sarno, Chrysafios Girasis, et al.
Journal of the American College of Cardiology|October 22, 2013
Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trialVasim Farooq, Patrick W Serruys, Yaojun Zhang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudyJoanna J Wykrzykowska, Lorenz Räber, Ton de Vries, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2014
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX studyChristos V Bourantas, Yao-Jun Zhang, Scot Garg, et al.
JACC. Cardiovascular Interventions|May 11, 2019
Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance DocumentErnest Spitzer, Eugene McFadden, Pascal Vranckx, et al.
Circulation|June 15, 2013
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX scoreVasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
JACC. Cardiovascular Interventions|September 26, 2009
Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudyJoanna J Wykrzykowska, Patrick W Serruys, Yoshinobu Onuma, et al.
International Journal of Cardiology|September 3, 2013
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) TrialVasim Farooq, Patrick W Serruys, Pascal Vranckx, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys, Scot Garg, Alexandre Abizaid, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymerScot Garg, Giovanna Sarno, Patrick W Serruys, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Interventions|June 25, 2011
A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trialsScot Garg, Giovanna Sarno, Chrysafios Girasis, et al.
Journal of the American College of Cardiology|October 22, 2013
Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trialVasim Farooq, Patrick W Serruys, Yaojun Zhang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudyJoanna J Wykrzykowska, Lorenz Räber, Ton de Vries, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2014
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX studyChristos V Bourantas, Yao-Jun Zhang, Scot Garg, et al.
JACC. Cardiovascular Interventions|May 11, 2019
Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance DocumentErnest Spitzer, Eugene McFadden, Pascal Vranckx, et al.
Circulation|June 15, 2013
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX scoreVasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
JACC. Cardiovascular Interventions|September 26, 2009
Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudyJoanna J Wykrzykowska, Patrick W Serruys, Yoshinobu Onuma, et al.
International Journal of Cardiology|September 3, 2013
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) TrialVasim Farooq, Patrick W Serruys, Pascal Vranckx, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys, Scot Garg, Alexandre Abizaid, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymerScot Garg, Giovanna Sarno, Patrick W Serruys, et al.
Pageof 4